[
  {
    "date": "2023-12-31",
    "symbol": "APLM",
    "period": "FY",
    "documenttype": "20-F",
    "amendmentflag": "false",
    "documentperiodenddate": "2023-12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "Apollomics Inc.",
    "entitycentralindexkey": 1944885,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityinteractivedatacurrent": "Yes",
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Non-accelerated Filer",
    "entitywellknownseasonedissuer": "No",
    "icfrauditorattestationflag": "true",
    "documentfinstmterrorcorrectionflag": "false",
    "entityshellcompany": "false",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "security12btitle": "Class A Ordinary Shares, par value $0.0001 per share",
    "tradingsymbol": "APLM",
    "securityexchangename": "NASDAQ",
    "entityfilenumber": "001-41670",
    "entityincorporationstatecountrycode": "E9",
    "contactpersonnelname": "Sanjeev Redkar",
    "entityaddressaddressline1": "989 E. Hillsdale Blvd., Suite 220",
    "entityaddresscityortown": "Foster City",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 94404,
    "cityareacode": 650,
    "localphonenumber": "209-4055",
    "entityaddresscountry": "US",
    "documentregistrationstatement": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "documentaccountingstandard": "International Financial Reporting Standards",
    "auditorname": "Grant Thornton LLP",
    "auditorfirmid": 248,
    "auditorlocation": "San Francisco, California",
    "otherincome": 1217000,
    "gainslossesonexchangedifferencesontranslationnetoftax": 1191000,
    "gainslossesonfinancialassetsatfairvaluethroughprofitorloss": 821000,
    "gainslossesonfinancialliabilitiesatfairvaluethroughprofitorloss": 1597000,
    "fairvaluechangeofconvertiblepreferredshares": 76430000,
    "researchanddevelopmentexpense": 34193000,
    "administrativeexpense": 20641000,
    "financecosts": 150000,
    "otherexpensebyfunction": 46003000,
    "profitlossbeforetax": -172591000,
    "incometaxexpensecontinuingoperations": 10000,
    "profitloss": -172601000,
    "basicearningslosspershare": -2.32,
    "dilutedearningslosspershare": -2.32,
    "propertyplantandequipment": 161000,
    "rightofuseassets": 425000,
    "intangibleassetsotherthangoodwill": 14757000,
    "longtermdeposits": 119000,
    "noncurrentassets": 15462000,
    "currentdepositsprepaymentsanddeferredexpenses": 2108000,
    "currentfinancialassetsatfairvaluethroughprofitorloss": 5761000,
    "cashandcashequivalents": 32056000,
    "currentassets": 39925000,
    "assets": 55387000,
    "currentotherpayablesandaccruals": 9162000,
    "shorttermborrowings": 4236000,
    "currentleaseliabilities": 158000,
    "currentliabilities": 13556000,
    "currentassetsliabilities": 26369000,
    "assetslesscurrentliabilities": 41831000,
    "noncurrentleaseliabilities": 267000,
    "noncurrentwarrantliability": 330000,
    "noncurrentliabilities": 597000,
    "netassetsliabilities": 41234000,
    "issuedcapital": 9000,
    "treasuryshares": 68000,
    "sharepremium": 661474000,
    "reserves": 26716000,
    "retainedearnings": -646965000,
    "equity": 41234000,
    "numberofsharesoutstanding": 89495790,
    "stockissuedthroughexerciseofstockoptionsshares": 62443,
    "increasedecreasethroughexerciseofoptions": 85000,
    "forfeitureofvestedshareoptionsequityvalue": -198000,
    "restrictedshareawardsvestedshares": 496752,
    "restrictedshareawardsvestedvalue": 68000,
    "stockissuedduringperiodsharesbusinesscombinationnetofredemptions": 3312715,
    "stockissuedduringperiodvaluebusinesscombinationnetofredemptions": 757000,
    "stockissuedduringperiodsharesconvesionofpreferredstockintoordinaryshares": 54420956,
    "increasedecreasethroughconversionofconvertibleinstruments": 6000,
    "ifrs2listingexpense": 45524000,
    "stockissuedduringperiodsharespostclosingapollomicsissuedtopipeinvestorsnetoftransactionscosts": 230000,
    "stockissuedduringperiodvaluepostclosingapollomicsissuedtopipeinvestorsnetoftransactionscosts": 261000,
    "reclassificationfromequitytononcurrentliabilitiesformaxprowarrantsassumedbyapollomicsuponclosing": -7105000,
    "stockissuedduringperiodsharesconvesionofclassaordinarysharesintoseriesapreferredshares": 2668750,
    "stockissuedduringperiodvalueconvesionofclassaordinarysharesintoseriesapreferredshares": 21350000,
    "increasedecreasethroughsharebasedpaymenttransactions": 12686000,
    "increasedecreasethroughportionofpipeissuancecostsallocatedtopipewarrants": 38000,
    "numberofordinarysharesissuedinexchangeofpreclosingbusinesscombinationordinaryshares": 31241,
    "stockissuedduringtheperiodexerciseofstockoptionsshares": 62443,
    "decreaseinsharepremiumduetoreclassificationofwarrantsfromequitytoliabilities": 7100000,
    "increaseofwarrantliabilityduetorecalcificationfromequity": 1300000,
    "decreaseinaccumulatedlossesduetoreclassificationofwarrantsfromequitytoliabilities": 5800000,
    "netimpactofequitybyreductionofpremiumduetorecalcificationofwarrants": 1300000,
    "adjustmentsforinterestincome": 821000,
    "adjustmentsfordepreciationofplantandequipment": 83000,
    "adjustmentsfordepreciationofrightofuseassets": 566000,
    "adjustmentsforamortisationexpense": 20000,
    "adjustmentsforgainlossondisposalspropertyplantandequipment": -188000,
    "adjustmentsforrealizedforeignexchangelossesgains": -21000,
    "adjustmentsforfairvaluechangeoffinancialliabilitiesatfvtpl": -1597000,
    "adjustmentsforfairvaluechangeofpreferredshares": 76430000,
    "adjustmentsforifrstwolistingexpense": 45524000,
    "issuancecosts": 38000,
    "adjustmentsforfinancecosts": 122000,
    "adjustmentsforsharebasedpayments": 12685000,
    "adjustmentsforunrealisedforeignexchangelossesgains": -258000,
    "cashflowsfromusedinoperationsbeforechangesinworkingcapital": -39632000,
    "adjustmentsforincreasedecreaseindepositsprepaymentsanddeferredexpenses": -932000,
    "adjustmentsforincreasedecreaseinothercurrentliabilities": -2635000,
    "cashflowsfromusedinoperations": -43199000,
    "interestpaidclassifiedasoperatingactivities": 10000,
    "cashflowsfromusedinoperatingactivities": -43209000,
    "interestreceivedclassifiedasinvestingactivities": 821000,
    "proceedsfromredemptionoflongtimedepositswithoriginalmaturityoverthreemonthsclassifiedasinvestingactivities": 4308000,
    "proceedsfromredemptionoftimedepositswithoriginalmaturityoverthreemonthsclassifiedasinvestingactivities": 2872000,
    "purchaseofpropertyplantandequipmentclassifiedasinvestingactivities": 6000,
    "proceedsfromsalesofpropertyplantandequipmentclassifiedasinvestingactivities": 58000,
    "proceedsfromsalesormaturityoffinancialinstrumentsclassifiedasinvestingactivities": 13307000,
    "refundofrentaldepositsclassifiedasinvestingactivities": 5000,
    "cashflowsfromusedininvestingactivities": 21365000,
    "proceedsfrompipefinancingandbusinesscombinationnetoftransactioncosts": 20249000,
    "paymentofdeferredunderwritingfees": 2779000,
    "proceedsfrombankloans": 4236000,
    "proceedsfromexerciseofoptions": 85000,
    "interestpaidclassifiedasfinancingactivities": 122000,
    "paymentsofleaseliabilitiesclassifiedasfinancingactivities": 444000,
    "cashflowsfromusedinfinancingactivities": 21225000,
    "increasedecreaseincashandcashequivalents": -619000,
    "nameofsubsidiary": "Apollomics, Inc.",
    "countryofincorporation": "California, United States",
    "dateofincorporation": "2016-01-14",
    "descriptionofnatureofentitysoperationsandprincipalactivities": "Research and development of drugs",
    "federalmoneymarketfund": 37800000,
    "financialliabilitiesatfairvaluethroughprofitorloss": 330000,
    "leaseliabilities": 425000,
    "numberofshareoptionsgrantedinsharebasedpaymentarrangement": 3048310,
    "revenuefrominterest": 753000,
    "revenuefromgovernmentgrants": 464000,
    "incomefromgovernmentgrantsrelatedtosubsidiesforresearchanddevelopmentactivity": 635000,
    "interestexpenseonleaseliabilities": 150000,
    "currenttaxexpenseincome": 10000,
    "accountingprofit": -172591000,
    "taxexpenseincomeatapplicabletaxrate": -36244000,
    "taxeffectofexpensenotdeductibleindeterminingtaxableprofittaxloss": 568000,
    "taxeffectofadditionalqualifiedexpensesdeductiblefortaxpurpose": -741000,
    "taxeffectofresearchanddevelopmentcredits": -2311000,
    "taxeffectoftaxlossesnoterecognized": 10277000,
    "taxeffectofforeigntaxrates": -28461000,
    "applicabletaxrate": 0.21,
    "percentageofincometaxdeductioninrespectofqualifyingresearchanddevelopmentexpendituresincurred": 0.75,
    "salariesandotherallowances": 10356000,
    "postemploymentbenefitexpenseinprofitorloss": 499000,
    "expensefromsharebasedpaymenttransactionswithemployees": 12685000,
    "employeebenefitsexpense": 23540000,
    "depreciationpropertyplantandequipment": 87000,
    "depreciationrightofuseassets": 587000,
    "amortisationintangibleassetsotherthangoodwill": 20000,
    "otherexpensebynature": 46003000,
    "weightedaverageshares": 74411000,
    "adjustedweightedaverageshares": 74411000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 12132460,
    "disposalspropertyplantandequipment": 363000,
    "retirementspropertyplantandequipment": -75000,
    "usefullifemeasuredasperiodoftimepropertyplantandequipment": "P3Y",
    "depreciationratepropertyplantandequipment": 0.2,
    "additionstorightofuseassets": 12000,
    "derecognitionofrightofuseassetsuponendofleaseterm": -291000,
    "derecognitionofrightofuseassetsaccumulateddepreciationuponendofleasetermandforeignexchangeeffect": 296000,
    "expenserelatingtoshorttermleasesforwhichrecognitionexemptionhasbeenused": 122000,
    "cashoutflowforleases": 566000,
    "leaseterm": "P12M",
    "additionsotherthanthroughbusinesscombinationsintangibleassetsotherthangoodwill": 7500000,
    "usefullifemeasuredasperiodoftimeintangibleassetsotherthangoodwill": "P10Y",
    "deferredtaxliabilityasset": -11000,
    "deferredtaxexpenseincomerecognisedinprofitorloss": 40000,
    "unusedtaxlossesforwhichnodeferredtaxassetrecognised": 97607000,
    "deductibletemporarydifferencesforwhichnodeferredtaxassetisrecognised": 17221000,
    "unusedtaxcreditsforwhichnodeferredtaxassetrecognised": 7462000,
    "increasedecreasethroughnetexchangedifferencesdeferredtaxliabilityasset": 2190000,
    "otherprepaymentscurrent": 1073000,
    "prepaidtaxes1": 312000,
    "valueaddedtaxreceivables": 466000,
    "shorttermdepositsclassifiedascashequivalents": 7000,
    "currentadvancestosuppliers": 250000,
    "timedepositsinterestrate": 0.037,
    "currentpayablesresearchanddevelopmentexpenses": 4471000,
    "accruedsalariesandbonusescurrent": 2166000,
    "accruedotherexpensescurrent": 1025000,
    "currentdepositsfromcustomers": 1000000,
    "otherspayable": 500000,
    "weightedaveragelesseesincrementalborrowingrateappliedtoleaseliabilitiesrecognisedatdateofinitialapplicationofifrs16": 0.0475,
    "preferredstocksharesissuedduringtheperiodshares": 88038389,
    "preferredstocksubscriptionpricepershare": 0.04543,
    "preferredstocksharesissuedduringtheperiodvalue": 4000000,
    "gainslossesrecognisedinprofitorlossfairvaluemeasurementliabilities": 76424000,
    "conversionofconvertiblepreferredsharesintopostclosingordinarysharesfairvaluemeasurementliabilities": -588285000,
    "dividendrateonpreferredstock": 0.08,
    "periodwithinwhichtheredemptionfeautureshallberestoredfromthedateonwhichtheissueisclosed": "P18M",
    "convertiblepreferredstockredemptionpriceasapercentageoforiginalissueprice": 1,
    "interestratepayableonredeemableamountofconvertiblepreferredstock": 0.12,
    "convertiblepreferredstockliquidationpreferencepercentage": 1,
    "interestratepayableonredeemablepreferredstock": 0.12,
    "numberofsharesauthorised": 600000000,
    "valueofsharesauthorized": 3,
    "numberofsharesissuedandfullypaid": 89495790,
    "stocksharesissuedduringtheperiodexerciseofstockoptionsshares": 62443,
    "parvaluepershare": 0.0001,
    "conversionofpreclosingapollomicsconvertiblepreferredsharesintopostclosingapollomicsordinaryshares": 54420956,
    "businesscombinationnetofredemptions": 3312715,
    "valueofconversionofpreclosingapollomicsconvertiblepreferredsharesintopostclosingapollomicsordinaryshares": 6,
    "postlosingapollomicsclassbordinarysharesissuedtopipeinvestorsnetoftransactioncosts": 230000,
    "issuanceofpostclosingapollomicsclassaordinarysharesupontheconversionofpostclosingapollomicsseriesapreferredshares": 2668750,
    "weightedaverageexercisepriceofshareoptionsexercisedinsharebasedpaymentarrangement2019": 0.28,
    "decreaseintreasurysharessharesearlyexerciseofshareoptionsvested": 6930235,
    "earlyexerciseofshareoptionsvestedduringtheperiodtreasurysharespricepershare": 0.26,
    "decreaseintreasurysharesvalueearlyexerciseofshareoptionsvested": -68,
    "shareexchangeratio": 0.071679,
    "sharebasedcompensationbysharebasedawardnumberofsharesauthorizedforissuance": 337225866,
    "noticeperiodthresholdpostterminationofemploymentrepurchaseoption": "P60D",
    "expensefromsharebasedpaymenttransactionsinwhichgoodsorservicesreceiveddidnotqualifyforrecognitionasassets": 12685,
    "weightedaverageexercisepriceofotherequityinstrumentsgrantedinsharebasedpaymentarrangement2019": 0.003,
    "sharebasedcompensationbysharebasedawardvestingperiod": "P48M",
    "sharebasedcompensationbysharebasedawardinitialvestingpercentage": 0.25,
    "sharebasedcompensationbysharebasedawardremainingvestingperiod": "P36M",
    "sharebasedcompensationbysharebasedawardequityinstrumentsotherthanoptionsvestedduringtheperiod": 496752,
    "descriptionofoptionlifeshareoptionsgranted": 10,
    "weightedaverageremainingcontractuallifeofoutstandingshareoptions2019": "P6Y3M",
    "weightedaveragefairvaluepershareofoptionsgranted": 7.13,
    "sharebasedcompensationbysharebasedawardvestingperiodminimum": "P24M",
    "sharebasedcompensationbysharebasedawardvestingperiodmaximum": "P48M",
    "sharebasedcompensationbysharebasedawardinitialvestingpercentageone": 0.5,
    "sharebasedcompensationbysharebasedawardinitialvestingpercentagetwo": 0.25,
    "sharebasedcompensationbysharebasedawardremainingvestingperiodminimum": "P12M",
    "sharebasedcompensatonbysharebasedawardremainingvestingperiodmaximum": "P36M",
    "numberofshareoptionsexercisedinsharebasedpaymentarrangement": -62443,
    "allocatedsharebasedcompensationconsultingfees": 19,
    "numberofotherequityinstrumentsoutstandinginsharebasedpaymentarrangement": 207945,
    "numberofotherequityinstrumentsvestedinasharebasedpaymentarrangementduringtheperiod": -6930235,
    "numberofoutstandingshareoptions": 11924415,
    "numberofshareoptionsforfeitedinsharebasedpaymentarrangement": -808341,
    "numberofshareoptionsexercisableinsharebasedpaymentarrangement": 7859478,
    "weightedaverageexercisepriceofshareoptionsoutstandinginsharebasedpaymentarrangement2019": 4.615,
    "weightedaverageexercisepriceofshareoptionsgrantedinsharebasedpaymentarrangement2019": 9.927,
    "weightedaverageexercisepriceofshareoptionsforfeitedinsharebasedpaymentarrangement2019": 0.57,
    "grantdateoptionfairvaluepershare": 0.01,
    "exercisepriceshareoptionsgranted2019": 0.07,
    "convertedgrantdateoptionfairvaluepershare": 0.14,
    "convertedexercisepriceshareoptionsgranted2019": 0.94,
    "descriptionofexpectedvolatilityshareoptionsgranted": 0.725,
    "descriptionofriskfreeinterestrateshareoptionsgranted": 0.0367,
    "numberofinstrumentsotherequityinstrumentsgranted": 207945,
    "weightedaverageexercisepriceofotherequityinstrumentsoutstandinginsharebasedpaymentarrangement2019": 5.41,
    "descriptionofvaluationtechniquesusedinfairvaluemeasurementassets": "Redemption value quoted by banks with reference to the expected return of the underlying assets",
    "descriptionofvaluationtechniquesusedinfairvaluemeasurementliabilities": "Black-Scholes model and OPM method - the key inputs are: time to liquidation, risk-free rate, expected volatility and possibilities for IPO/liquidation scenario",
    "descriptionofinputsusedinfairvaluemeasurementliabilities": "Possibilityfor IPOscenario (note)",
    "descriptionofsensitivityoffairvaluemeasurementtochangesinunobservableinputsliabilities": "The higher the possibility for IPO scenario, the higher the fair value, and vice versa",
    "financialassetsatfairvaluethroughprofitorloss": 5761000,
    "financialassetsatamortisedcost": 32166000,
    "financialliabilitiesatamortisedcost": 5970000,
    "financialassets": 6071000,
    "financialliabilities": 5443000,
    "effectonlossduetofluctuationofforeignexchangerate": 659000,
    "descriptionofinternalcreditratingsprocess": "The counterparty has a low risk of default and does not have any past-due amounts",
    "descriptionoftypeofmeasurementofexpectedcreditlossesfinancialassetsatamortizedcost": "12-month ECL",
    "otherpayablesundiscountedcashflows": 5970000,
    "nonderivativefinancialliabilitiesundiscountedcashflowsexcludingleaseliabilities": 5970000,
    "grossleaseliabilities": 44000,
    "convertiblepreferredsharescarryingamount": 133529000,
    "otherpayables": 5970000,
    "nonderivativefinancialliabilities": 5970000,
    "percentageofdecreaseinforeignexchangerate": 0.05,
    "percentageofdecreaseincreaseinforeignexchangerate": 0.05,
    "percentageofincreaseinforeignexchangerate": 0.05,
    "percentageofreasonablypossibleincreaseinunobservableinputliabilities": 0.1,
    "increasedecreaseinfairvaluemeasurementduetoreasonablypossibleincreaseinunobservableinputliabilities": 41969000,
    "gainslossesrecognisedinprofitorlossexcludingexchangedifferencesfairvaluemeasurementliabilities": 76400000,
    "postemploymentbenefitexpensedefinedbenefitplans": 499000,
    "keymanagementpersonnelcompensationshorttermemployeebenefits": 4112000,
    "keymanagementpersonnelcompensationpostemploymentbenefits": 21000,
    "keymanagementpersonnelcompensationsharebasedpayment": 9419000,
    "keymanagementpersonnelcompensation": 13552000,
    "liabilitiesarisingfromfinancingactivities": 425000,
    "increasedecreasethroughfinancingcashflowsliabilitiesarisingfromfinancingactivities": -688000,
    "increasedecreasethroughchangesinfairvaluesliabilitiesarisingfromfinancingactivities": 76424000,
    "increasedecreasethroughpreferredsharesconvertedtocommonstockfairvaluesliabilitiesarisingfromfinancingactivities": -588285000,
    "increasedecreasethroughinterestexpenseliabilitiesarisingfromfinancingactivities": 122000,
    "restrictednetassets": 52298000,
    "shareofprofitlossofassociatesandjointventuresaccountedforusingequitymethod": -31610000,
    "investmentsinsubsidiaries": 70103000,
    "deficitinsubsidiaries": 38653000,
    "adjustmentsforundistributedprofitsofinvestmentsaccountedforusingequitymethod": 31610000,
    "adjustmentsforfairvaluegainslossesoffinancialassets": -821000,
    "adjustmentsforfairvaluechangeofconvertiblepreferredshares": 76430000,
    "adjustmentsforportionofpipeissuancecostsallocatedtopipewarrants": 38000,
    "otheradjustmentsfornoncashitems": 2484000,
    "cashflowsusedinobtainingcontrolofsubsidiariesorotherbusinessesclassifiedasinvestingactivities": 8042000,
    "cashreceiptsfromrepaymentofadvancesandloansmadetorelatedparties": 457000,
    "minimumpercentageofrestrictednetassetsofconsolidatedandunconsolidatedsubsidiariestoconsolidatednetassetstofilecondensedfinancialinformation": 0.25
  },
  {
    "date": "2022-12-31",
    "symbol": "APLM",
    "period": "FY",
    "documenttype": "20-F",
    "amendmentflag": "false",
    "documentperiodenddate": "2022-12-31",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "Apollomics Inc.",
    "entitycentralindexkey": 1944885,
    "entitycurrentreportingstatus": "No",
    "entityvoluntaryfilers": "No",
    "entityinteractivedatacurrent": "Yes",
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Non-accelerated Filer",
    "entitywellknownseasonedissuer": "No",
    "icfrauditorattestationflag": "false",
    "entityshellcompany": "false",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "security12btitle": "Class A ordinary shares, par value $0.0001 per share",
    "tradingsymbol": "APLM",
    "securityexchangename": "NASDAQ",
    "entityfilenumber": "001-41670",
    "entityincorporationstatecountrycode": "E9",
    "contactpersonnelname": "Sanjeev Redkar",
    "entityaddressaddressline1": "989 E. Hillsdale Blvd., Suite 220",
    "entityaddresscityortown": "Foster City",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 94404,
    "cityareacode": 650,
    "localphonenumber": "209-4055",
    "documentregistrationstatement": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "documentaccountingstandard": "International Financial Reporting Standards",
    "auditorname": "Deloitte Touche Tohmatsu Certified Public Accountants LLP",
    "auditorfirmid": 1113,
    "auditorlocation": "Shenzhen, the People’s Republic of China",
    "otherincome": 1447000,
    "othergainslosses": -829000,
    "gainslossesonfinancialassetsatfairvaluethroughprofitorloss": 323000,
    "fairvaluechangeofconvertiblepreferredshares": 189646000,
    "researchanddevelopmentexpense": 35457000,
    "administrativeexpense": 9947000,
    "financecosts": 93000,
    "otherexpensebyfunction": 6608000,
    "profitlossbeforetax": -240810000,
    "incometaxexpensecontinuingoperations": 1000,
    "profitloss": -240811000,
    "basicearningslosspershare": -0.62,
    "dilutedearningslosspershare": -0.62,
    "propertyplantandequipment": 485000,
    "rightofuseassets": 991000,
    "intangibleassetsotherthangoodwill": 14778000,
    "longtermdeposits": 124000,
    "noncurrenttimedeposits": 4307000,
    "noncurrentassets": 20685000,
    "currentdepositsprepaymentsanddeferredexpenses": 1176000,
    "currentfinancialassetsatfairvaluethroughprofitorloss": 19067000,
    "currenttimedeposits": 2872000,
    "cashandcashequivalents": 32675000,
    "currentassets": 55790000,
    "assets": 76475000,
    "currentotherpayablesandaccruals": 11675000,
    "currentfinancialliabilitiesarisingfromunvestedrestrictedshares": 68000,
    "currentleaseliabilities": 614000,
    "currentliabilities": 12357000,
    "currentassetsliabilities": 43433000,
    "assetslesscurrentliabilities": 64118000,
    "noncurrentleaseliabilities": 377000,
    "noncurrentconvertiblepreferredsharesliability": 511861000,
    "noncurrentliabilities": 512238000,
    "netassetsliabilities": -448120000,
    "issuedcapital": 41000,
    "treasuryshares": 68000,
    "sharepremium": 12279000,
    "otherreserves": 14228000,
    "retainedearnings": -474600000,
    "equity": -448120000,
    "numberofsharesoutstanding": 401804327,
    "stockissuedthroughexerciseofstockoptionsshares": 8552187,
    "increasedecreasethroughexerciseofoptions": 1000,
    "forfeitureofvestedshareoptionsequityvalue": -1646000,
    "restrictedshareawardsvestedshares": -1164666,
    "restrictedshareawardsvestedvalue": 21000,
    "earlyexercisedshareoptionsvestedduringtheyearshares": -5991847,
    "earlyexercisedshareoptionsvestedduringtheyearvalue": 1558000,
    "increasedecreasethroughsharebasedpaymenttransactions": 3582000,
    "adjustmentsforinterestincome": 431000,
    "adjustmentsfordepreciationofplantandequipment": 162000,
    "adjustmentsfordepreciationofrightofuseassets": 593000,
    "adjustmentsforamortisationexpense": 20000,
    "adjustmentsforunrealisedforeignexchangelossesgains": 663000,
    "adjustmentsforfairvaluegainslosses": -323000,
    "adjustmentsforfairvaluechangeofconvertiblepreferredshares": 189646000,
    "adjustmentsforfinancecosts": 93000,
    "adjustmentsforsharebasedpayments": 3582000,
    "otheradjustmentsfornoncashitems": -2563000,
    "cashflowsfromusedinoperationsbeforechangesinworkingcapital": -49368000,
    "adjustmentsforincreasedecreaseindepositsprepaymentsanddeferredexpenses": 3651000,
    "adjustmentsforincreasedecreaseinothercurrentliabilities": 2837000,
    "cashflowsfromusedinoperations": -42880000,
    "incometaxesrefundclassifiedasoperatingactivities": 57000,
    "interestpaidclassifiedasoperatingactivities": 1000,
    "cashflowsfromusedinoperatingactivities": -42824000,
    "interestreceivedclassifiedasinvestingactivities": 431000,
    "proceedsfromredemptionoftimedepositswithoriginalmaturityoverthreemonthsclassifiedasinvestingactivities": 24000000,
    "purchaseofpropertyplantandequipmentclassifiedasinvestingactivities": 367000,
    "proceedsfromsalesormaturityoffinancialinstrumentsclassifiedasinvestingactivities": 5000000,
    "paymentforrentaldepositsclassifiedasinvestingactivities": 17000,
    "refundofrentaldepositsclassifiedasinvestingactivities": 6000,
    "cashflowsfromusedininvestingactivities": 29053000,
    "proceedsfromexerciseofoptions": 392000,
    "interestpaidclassifiedasfinancingactivities": 93000,
    "paymentsofleaseliabilitiesclassifiedasfinancingactivities": 593000,
    "cashflowsfromusedinfinancingactivities": -294000,
    "increasedecreaseincashandcashequivalents": -14065000,
    "nameofsubsidiary": "Apollomics, Inc.",
    "countryofincorporation": "California, United States",
    "dateofincorporation": "2016-01-14",
    "descriptionofnatureofentitysoperationsandprincipalactivities": "Research and development of drugs",
    "liabilities": 448120000,
    "financialliabilitiesatfairvaluethroughprofitorloss": 511861000,
    "leaseliabilities": 991000,
    "noncurrentassetsotherthanfinancialinstrumentsdeferredtaxassetspostemploymentbenefitassetsandrightsarisingunderinsurancecontracts": 13712000,
    "incomefromgovernmentgrantsrelatedtosubsidiesforresearchanddevelopmentactivity": 1353,
    "revenuefrominterest": 431000,
    "revenuefromgovernmentgrants": 1016000,
    "gainslossesonexchangedifferencesontranslationnetoftax": -829000,
    "interestexpenseonleaseliabilities": 93000,
    "currenttaxexpenseincome": 1000,
    "accountingprofit": -240810000,
    "taxexpenseincomeatapplicabletaxrate": -50570000,
    "taxeffectofexpensenotdeductibleindeterminingtaxableprofittaxloss": 45739000,
    "taxeffectofrevenuesexemptfromtaxation2011": 257000,
    "taxeffectofadditionalqualifiedexpensesdeductiblefortaxpurpose": -1517000,
    "taxeffectoftaxlossesnoterecognized": 7027000,
    "taxeffectofforeigntaxrates": -421000,
    "applicabletaxrate": 0.21,
    "percentageofincometaxdeductioninrespectofqualifyingresearchanddevelopmentexpendituresincurred": 0.75,
    "profitlossfromoperatingactivities": 976000,
    "taxrecoverable": 205000,
    "salariesandotherallowances": 14966000,
    "postemploymentbenefitexpenseinprofitorloss": 662000,
    "expensefromsharebasedpaymenttransactionswithemployees": 3582000,
    "employeebenefitsexpense": 19210000,
    "depreciationpropertyplantandequipment": 162000,
    "depreciationrightofuseassets": 593000,
    "amortisationintangibleassetsotherthangoodwill": 20000,
    "otherexpensebynature": 6608000,
    "weightedaverageshares": 390944000,
    "adjustedweightedaverageshares": 390944000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 132057583,
    "additionsotherthanthroughbusinesscombinationspropertyplantandequipment": 367000,
    "depreciationratepropertyplantandequipment": 0.2,
    "additionstorightofuseassets": 538000,
    "derecognitionofrightofuseassetsuponendofleaseterm": -40000,
    "derecognitionofrightofuseassetsaccumulateddepreciationuponendofleaseterm": 40000,
    "expenserelatingtoshorttermleasesforwhichrecognitionexemptionhasbeenused": 96000,
    "cashoutflowforleases": 782000,
    "usefullifemeasuredasperiodoftimeintangibleassetsotherthangoodwill": "P10Y",
    "deferredtaxliabilityasset": -51000,
    "deferredtaxexpenseincomerecognisedinprofitorloss": -19000,
    "unusedtaxlossesforwhichnodeferredtaxassetrecognised": 63478000,
    "otherprepaymentscurrent": 624000,
    "valueaddedtaxreceivables": 547000,
    "shorttermdepositsclassifiedascashequivalents": 5000,
    "timedepositsinterestrate": 0.037,
    "descriptionofperiodswhencashflowsexpectedtooccur": "12 months",
    "currentresearchanddevelopmentexpensepayable": 5435000,
    "accruedsalariesandbonusescurrent": 2475000,
    "accruedotherexpensescurrent": 1662000,
    "currentdepositsfromcustomers": 1000000,
    "otherspayable": 1103000,
    "currentfinancialliabilitiesatamortisedcost": 68000,
    "weightedaveragelesseesincrementalborrowingrateappliedtoleaseliabilitiesrecognisedatdateofinitialapplicationofifrs16": 0.0475,
    "preferredstocksharesissuedduringtheperiodshares": 88038389,
    "preferredstocksubscriptionpricepershare": 0.04543,
    "preferredstocksharesissuedduringtheperiodvalue": 4000000,
    "gainslossesrecognisedinprofitorlossfairvaluemeasurementliabilities": 189646000,
    "significantunobservableinputliabilities": 1.25,
    "dividendrateonpreferredstock": 0.08,
    "conversionratioofpreferredsharesintoequity": 1,
    "periodwithinwhichtheredemptionfeautureshallberestoredfromthedateonwhichtheissueisclosed": "P18M",
    "convertiblepreferredstockredemptionpriceasapercentageoforiginalissueprice": 1,
    "interestratepayableonredeemableamountofconvertiblepreferredstock": 0.12,
    "convertiblepreferredstockliquidationpreferencepercentage": 1,
    "interestratepayableonredeemablepreferredstock": 0.12,
    "numberofsharesauthorised": 444343488,
    "valueofsharesauthorized": 44,
    "numberofsharesissuedandfullypaid": 401804327,
    "stocksharesissuedduringtheperiodexerciseofstockoptionsshares": 8552187,
    "parvaluepershare": 0.0001,
    "stockissuedduringtheperiodexerciseofstockoptionsshares": 498958,
    "weightedaverageexercisepriceofshareoptionsexercisedinsharebasedpaymentarrangement2019": 0.01,
    "sharesinentityheldbyentityorbyitssubsidiariesorassociates": 6930235,
    "decreaseintreasurysharessharesrestrictedsharesvested": -1164666,
    "restrictedsharesvestedduringtheperiodtreasurysharespricepershare": 0.01,
    "decreaseintreasurysharesvaluerestrictedsharesvested": -21000,
    "decreaseintreasurysharessharesearlyexerciseofshareoptionsvested": -5991847,
    "earlyexerciseofshareoptionsvestedduringtheperiodtreasurysharespricepershare": 0.26,
    "decreaseintreasurysharesvalueearlyexerciseofshareoptionsvested": -1558000,
    "sharebasedcompensationbysharebasedawardnumberofsharesauthorizedforissuance": 337225866,
    "noticeperiodthresholdpostterminationofemploymentrepurchaseoption": "P60D",
    "expensefromsharebasedpaymenttransactionsinwhichgoodsorservicesreceiveddidnotqualifyforrecognitionasassets": 39000,
    "weightedaverageexercisepriceofotherequityinstrumentsgrantedinsharebasedpaymentarrangement2019": 0.003,
    "sharebasedcompensationbysharebasedawardvestingperiod": "P48M",
    "sharebasedcompensationbysharebasedawardinitialvestingpercentage": 0.25,
    "sharebasedcompensationbysharebasedawardremainingvestingperiod": "P36M",
    "descriptionofoptionlifeshareoptionsgranted": 10,
    "weightedaverageremainingcontractuallifeofoutstandingshareoptions2019": "P7Y4M24D",
    "weightedaveragefairvaluepershareofoptionsgranted": 0.1403,
    "sharebasedcompensationbysharebasedawardvestingperiodminimum": "P24M",
    "sharebasedcompensationbysharebasedawardvestingperiodmaximum": "P48M",
    "sharebasedcompensationbysharebasedawardinitialvestingpercentageone": 0.25,
    "sharebasedcompensationbysharebasedawardinitialvestingpercentagetwo": 0.5,
    "sharebasedcompensationbysharebasedawardremainingvestingperiodminimum": "P12M",
    "sharebasedcompensatonbysharebasedawardremainingvestingperiodmaximum": "P36M",
    "numberofshareoptionsexercisedinsharebasedpaymentarrangement": -8552187,
    "allocatedsharebasedcompensationconsultingfees": 27000,
    "numberofotherequityinstrumentsoutstandinginsharebasedpaymentarrangement": 6930235,
    "numberofotherequityinstrumentsvestedinasharebasedpaymentarrangementduringtheperiod": -1164666,
    "numberofoutstandingshareoptions": 135979705,
    "numberofshareoptionsgrantedinsharebasedpaymentarrangement": 11500000,
    "numberofshareoptionsforfeitedinsharebasedpaymentarrangement": -22027291,
    "numberofshareoptionsexercisableinsharebasedpaymentarrangement": 67667737,
    "weightedaverageexercisepriceofshareoptionsoutstandinginsharebasedpaymentarrangement2019": 0.217,
    "weightedaverageexercisepriceofshareoptionsgrantedinsharebasedpaymentarrangement2019": 0.31,
    "weightedaverageexercisepriceofshareoptionsforfeitedinsharebasedpaymentarrangement2019": 0.232,
    "grantdateoptionfairvaluepershare": 0.0933,
    "exercisepriceshareoptionsgranted2019": 0.31,
    "descriptionofexpectedvolatilityshareoptionsgranted": 0.75,
    "descriptionofriskfreeinterestrateshareoptionsgranted": 0.0135,
    "financialassetsatfairvaluethroughprofitorloss": 19067000,
    "financialassetsatamortisedcost": 39983000,
    "financialliabilitiesatamortisedcost": 7606000,
    "financialassets": 8940000,
    "financialliabilities": 1210000,
    "effectonlossduetofluctuationofforeignexchangerate": 386000,
    "descriptionofinternalcreditratingsprocess": "The counterparty has a low risk of default and does not have any past-due amounts",
    "descriptionoftypeofmeasurementofexpectedcreditlossesfinancialassetsatamortizedcost": "12-month ECL",
    "convertiblepreferredsharesweightedaverageinterestrate": 0.12,
    "convertiblepreferredsharesundiscountedcashflows": 338492000,
    "otherpayablesundiscountedcashflows": 7538000,
    "financialliabilitiesarisingfromunvestedrestrictedsharescashflows": 68000,
    "nonderivativefinancialliabilitiesundiscountedcashflowsexcludingleaseliabilities": 7606000,
    "grossleaseliabilities": 49000,
    "convertiblepreferredsharescarryingamount": 378332000,
    "otherpayables": 7538000,
    "financialliabilitiesarisingfromunvestedrestrictedshares": 68000,
    "nonderivativefinancialliabilities": 385938000,
    "descriptionofvaluationtechniquesusedinfairvaluemeasurementassets": "Redemption valuequoted by bankswith reference tothe expectedreturn of theunderlying assets",
    "descriptionofvaluationtechniquesusedinfairvaluemeasurementliabilities": "Black-scholesmodel and OPMmethod — thekey inputs are:time toliquidation, risk-free rate,expectedvolatility andpossibilities forIPO/liquidationscenario",
    "descriptionofinputsusedinfairvaluemeasurementliabilities": "Possibility forIPO scenario(note)",
    "descriptionofsensitivityoffairvaluemeasurementtochangesinunobservableinputsliabilities": "Thehigher thepossibilityfor IPOscenario,the higherthe fairvalue, andvice versa",
    "percentageofdecreaseinforeignexchangerate": 0.05,
    "percentageofdecreaseincreaseinforeignexchangerate": 0.05,
    "percentageofincreaseinforeignexchangerate": 0.05,
    "percentageofreasonablypossibleincreaseinunobservableinputliabilities": 0.1,
    "increasedecreaseinfairvaluemeasurementduetoreasonablypossibleincreaseinunobservableinputliabilities": 42888000,
    "increasedecreaseinfairvaluemeasurementduetoreasonablypossibledecreaseinunobservableinputliabilities": 41969000,
    "gainslossesrecognisedinprofitorlossexcludingexchangedifferencesfairvaluemeasurementliabilities": 189646000,
    "postemploymentbenefitexpensedefinedbenefitplans": 662000,
    "descriptionofnatureofrelatedpartyrelationship": "Executive director of the Company",
    "descriptionoftransactionswithrelatedparty": "Loan interest income",
    "keymanagementpersonnelcompensationshorttermemployeebenefits": 2473000,
    "keymanagementpersonnelcompensationpostemploymentbenefits": 12000,
    "keymanagementpersonnelcompensationsharebasedpayment": 1820000,
    "keymanagementpersonnelcompensation": 4305000,
    "liabilitiesarisingfromfinancingactivities": 511861000,
    "increasedecreasethroughfinancingcashflowsliabilitiesarisingfromfinancingactivities": -686000,
    "increasedecreasethroughchangesinfairvaluesliabilitiesarisingfromfinancingactivities": 189646000,
    "increasethroughnewleasesliabilitiesarisingfromfinancingactivities": 548000,
    "increasedecreasethroughissuecostsaccruedliabilitiesarisingfromfinancingactivities": -644000,
    "increasedecreasethroughinterestexpenseliabilitiesarisingfromfinancingactivities": 93000,
    "liabilitiesfromsharebasedpaymenttransactions2011": 1579000,
    "restrictednetassets": 52298000,
    "shareofprofitlossofassociatesandjointventuresaccountedforusingequitymethod": -43094000,
    "investmentsinsubsidiaries": 70560000,
    "deficitinsubsidiaries": 30611000,
    "adjustmentsforundistributedprofitsofinvestmentsaccountedforusingequitymethod": 43094000,
    "cashflowsusedinobtainingcontrolofsubsidiariesorotherbusinessesclassifiedasinvestingactivities": 25926000,
    "cashadvancesandloansmadetorelatedparties": 2013000,
    "cashreceiptsfromrepaymentofadvancesandloansmadetorelatedparties": 2135000,
    "minimumpercentageofrestrictednetassetsofconsolidatedandunconsolidatedsubsidiariestoconsolidatednetassetstofilecondensedfinancialinformation": 0.25
  }
]